Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjects

European Journal of Neurology

Volumn 21, Issue 10, 2014, Pages 1318-e81

  Yoon, C W ^a   Kang, M ^b   Shin, H Y ^b   Jeon, S ^c   Yang, J J ^c   Kim, S T ^b   Noh, Y ^d   Kim, G H ^e   Kim, H J ^b   Kim, Y J ^b   Kim, J H ^b   Cho, H ^f   Ye, B S ^g   Lee, J M ^c   Choi, S H ^a   Im, K ^h   Moon, H S ⁱ   Na, D L ^b   Seo, S W ^b  

^a Inha University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Hanyang University   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e Mokdong Hospital   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

C peptide; Cortical thinning; Insulin

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGE; ARTICLE; BLOOD EXAMINATION; BODY MASS; CEREBROVASCULAR ACCIDENT; CORTICAL THICKNESS (BRAIN); FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFERIOR TEMPORAL GYRUS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUPERIOR PARIETAL LOBULE; TEMPORAL LOBE; AGED; BLOOD; BRAIN CORTEX; HYPERINSULINISM; MIDDLE AGED; PATHOLOGY;

AGED; C-PEPTIDE; CEREBRAL CORTEX; FEMALE; HUMANS; HYPERINSULINISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84908897490     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12485     Document Type: Article

References (53)

1. Ott A, Stolk R, Van Harskamp F, Pols H, Hofman A, Breteler M. Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999; 53: 1937-1942.
2. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies. The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256-1262.
3. Xu W, Qiu CX, Wahlin Å, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project. A 6-year follow-up study. Neurology 2004; 63: 1181-1186.
4. MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002; 14: 77-83.
5. Luchsinger J, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65: 545-551.
6. Gao L, Matthews FE, Sargeant LA, Brayne C; MRC CFAS. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 2008; 8: 54-64.
7. Yaffe K, Blackwell T, Whitmer R, Krueger K, Barrett-Connor E. Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 2006; 10: 292-295.
8. Enzinger C, Fazekas F, Matthews P, et al. Risk factors for progression of brain atrophy in aging. Six-year follow-up of normal subjects. Neurology 2005; 64: 1704-1711.
9. Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy. The PATH Study. Neurology 2012; 79: 1019-1026.
10. Burns CM, Chen K, Kaszniak AW, et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 2013; 80: 1557-1564.
11. Rasgon NL, Kenna HA, Wroolie TE, et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 2011; 32: 1942-1948.
12. Luchsinger JA, Tang M-X, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187-1192.
13. Kalmijn S, Feskens E, Launer L, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096-1102.
14. Kenna H, Hoeft F, Kelley R, et al. Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Neurobiol Aging 2013; 34: 641-649.
15. Törn C. C peptide and autoimmune markers in diabetes. Clin Lab 2003; 49: 11-13.
16. Okereke OI, Pollak MN, Hu FB, Hankinson SE, Selkoe DJ, Grodstein F. Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes. Psychoneuroendocrinology 2008; 33: 455-461.
17. Okereke O, Hankinson SE, Hu FB, Grodstein F. Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch Intern Med 2005; 165: 1651.
18. Okereke O, Kang JH, Gaziano JM, Ma J, Stampfer MJ, Grodstein F. Plasma C-peptide and cognitive performance in older men without diabetes. Am J Geriatr Psych 2006; 14: 1041-1050.
19. Kramer JH, Mungas D, Reed BR, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007; 21: 412-418.
20. Jack CR, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009; 132: 1355-1365.
21. Hampel H, Burger K, Teipel SJ, Bokde ALW, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimer's Dement 2008; 4: 38-48.
22. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
23. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87-97.
24. Zijdenbos AP, Evans AC, Riahi F, Sled JG, Chui J, Kollokian V. Automatic quantification of multiple sclerosis lesion volume using stereotaxic space. Proc. 4th Intl. Conf. on Visualization in BioMed. Computing VBC Lecture Notes in Computer Science 1996; 1131: 439-448.
25. Kim JS, Singh V, Lee JK, et al. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 2005; 27: 210-221.
26. Im K, Lee JM, Lee J, et al. Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage 2006; 31: 31-38.
27. Lyttelton O, Boucher M, Robbins S, Evans A. An unbiased iterative group registration template for cortical surface analysis. Neuroimage 2007; 34: 1535-1544.
28. Im K, Lee JM, Yoon U, et al. Fractal dimension in human cortical surface: multiple regression analysis with cortical thickness, sulcal depth, and folding area. Hum Brain Mapp 2006; 27: 994-1003.
29. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2001; 15: 1-25.
30. Apostolova LG, Dinov ID, Dutton RA, et al. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 2006; 129: 2867-2873.
31. Thompson PM, Hayashi KM, Sowell ER, et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 2004; 23: S2-S18.
32. Luders E, Narr KL, Thompson PM, et al. Gender effects on cortical thickness and the influence of scaling. Hum Brain Mapp 2005; 27: 314-324.
33. Brundel M, van den Heuvel M, de Bresser J, Kappelle LJ, Biessels GJ. Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci 2010; 299: 126-130.
34. Leritz EC, Salat DH, Williams VJ, et al. Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage 2011; 54: 2659-2671.
35. Seo SW, Lee JM, Im K, et al. Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy. Alzheimer Dis Assoc Disord 2012; 26: 106-112.
36. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873-880.
37. Paradiso S, Chemerinski E, Yazici KM, Tartaro A, Robinson RG. Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damage. J Neurol Neurosurg Psychiatry 1999; 67: 664-667.
38. Coull J, Frith C. Differential activation of right superior parietal cortex and intraparietal sulcus by spatial and nonspatial attention. Neuroimage 1998; 8: 176-187.
39. Corbetta M, Miezin FM, Shulman GL, Petersen SE. A PET study of visuospatial attention. J Neurosci 1993; 13: 1202-1226.
40. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci 2003; 100: 4162-4167.
41. Gasparini L, Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 2003; 26: 404-406.
42. Freude S, Plum L, Schnitker J, et al. Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 2005; 54: 3343-3348.
43. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radical Biol Med 2000; 29: 1302-1306.
44. Soop M, Duxbury H, Agwunobi AO, et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab 2002; 282: E1276-E1285.
45. Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 2003; 92: 10-17.
46. Wheatcroft S, Williams I, Shah A, Kearney M. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003; 20: 255-268.
47. Shinozaki K, Naritomi H, Shimizu T, et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996; 27: 37-43.
48. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke 1998; 29: 1860-1866.
49. Kernan W, Inzucchi S, Viscoli C, Brass L, Bravata D, Horwitz R. Insulin resistance and risk for stroke. Neurology 2002; 59: 809-815.
50. Wannamethee SG, Perry IJ, Shaper AG. Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke 1999; 30: 1780-1786.
51. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 2000; 160: 1160-1168.
52. Duering M, Righart R, Csanadi E, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012; 79: 2025-2028.
53. Cardenas VA, Reed B, Chao LL, et al. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012; 43: 2865-2870.